PT Kalbe Farma Tbk (KLBF) Stock Price & Analysis
KLBF Stock Chart & Stats
- Day’s Range
- IDR 740.00 - IDR 770.00
- 52-Week Range
- IDR 630.00 - IDR 1,310.00
- Previous Close
- IDR 760.00
- Volume
- N/A
- Average Volume (3M)
- 53.89M
- Market Cap
- IDR 35.34T
- Enterprise Value
- IDR 29.19T
- Total Cash (Recent Filing)
- IDR 5.58T
- Total Debt (Recent Filing)
- IDR 295.10B
- Price to Earnings (P/E)
- 9.1
- Beta
- 0.59
- Next Earnings
- Apr 01, 2027 (Est.)
- EPS Estimate
- 21.25
- Last Dividend Ex-Date
- Jun 04, 2026
- Dividend Yield
- 2.65%
KLBF FAQ
What was PT Kalbe Farma Tbk’s price range in the past 12 months?
What is PT Kalbe Farma Tbk’s market cap?
When is PT Kalbe Farma Tbk’s upcoming earnings report date?
How were PT Kalbe Farma Tbk’s earnings last quarter?
Is PT Kalbe Farma Tbk overvalued?
Does PT Kalbe Farma Tbk pay dividends?
What is PT Kalbe Farma Tbk’s EPS estimate?
How many shares outstanding does PT Kalbe Farma Tbk have?
What happened to PT Kalbe Farma Tbk’s price movement after its last earnings report?
Which hedge fund is a major shareholder of PT Kalbe Farma Tbk?
What is the TipRanks Smart Score and how is it calculated?
Company Description
PT Kalbe Farma Tbk
PT Kalbe Farma Tbk., an Indonesian pharmaceutical leader, along with its subsidiaries, focuses on the development, manufacturing, and commercialization of pharmaceutical products across Indonesia. Its operations are structured into four primary divisions: Prescription Pharmaceuticals, Consumer Health, Nutritionals, and Distribution & Logistics. The company's diverse portfolio encompasses generic, branded, and licensed medications, including well-known names like Brainact, Cefspan, and Mycoral, which are supplied to hospitals, pharmacies, and various drugstores. Beyond prescription drugs, it offers non-prescription medicines, a range of energy and ready-to-drink beverages, dietary supplements, and other preventive health solutions. Kalbe Farma also produces specialized nutritional products tailored for all demographics, from infants to seniors, including expectant mothers and individuals with specific medical dietary needs. The firm extends contract services to other pharmaceutical companies, covering clinical study management, bioavailability/bioequivalence assessments, and analytical testing. Additionally, it provides animal health products and operates its own healthcare facilities, the Mitrasana Clinics. Its broad scope of activities further includes health screening, acting as an agent for biotechnology products, and the distribution of consumer items, medical devices, and cosmetics. The company also trades in medical and laboratory equipment and supplies, raw materials for pharmaceuticals, and consumables for hemodialysis therapy, in addition to offering advertising services. Founded in 1966, PT Kalbe Farma Tbk. is headquartered in Jakarta, Indonesia.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- CEO
- Bernadette Ruth Irawati Setiady
- Employees
- 12,806
- Website
- www.kalbe.co.id
- Address
- Gedung KALBE, Jakarta, JK, 10510, ID
PT Kalbe Farma Tbk (KLBF) Earnings & Revenues
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 12 | 4 | 6 |
| Technical Analysis | 3 | 4 | 3 |
| Moving Averages | 9 | 0 | 3 |
